Health Care: Drugs

Martek Biosciences Corporation (MATK: NASDAQ)

$31.49 -0.01 | -0.03%
02/25/11 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:09/26/08
Price Earnings Ratio:37.94
Price Earnings Comparisons:
MATKSector Avg.S&P 500
37.9437.9017.20
Price Performance History (% change):
3 Mo1 Yr3 Yr
42.1057.298.77
GROWTH12 Mo3 YrCAGR
Revenue30.400.470.13
Net Income-31.30-0.13-0.04
EPS-32.00-0.15-0.05
Earnings for MATK:
EBITDA123.60M
REVENUE450.02M
Average Earnings Estimates
Qtr (01/11) Qtr (04/11) FY (10/11) FY (10/12)
Average Estimate $0.38 $0.46 $1.67 $1.79
Number of Analysts 4 4 4 2
High Estimate $0.40 $0.53 $1.82 $1.94
Low Estimate $0.37 $0.42 $1.61 $1.63
Prior Year $0.31 $0.45 $1.55 $1.67
Growth Rate (Year over Year) 23.39% 2.22% 7.74% 6.89%

Portfolios with MATK

Latest MATK Headlines from TheStreet

More Financial News for MATK

Press Releases for MATK

See All Press Releases

Partner Headlines for MATK

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter